(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Body Vision Medical’s AI-Powered LungVision Gains TGA Approval in Australia
Body Vision Medical has received Therapeutic Goods Administration (TGA) approval in Australia for LungVision, an AI-powered imaging system designed to improve early lung cancer diagnosis. The company has partnered with ParagonCare to distribute the system in Australia and New Zealand.
LungVision converts any C-arm fluoroscope into a 3D imaging system, providing real-time navigation and enhanced visualization for accurate bronchoscopic biopsies. Its tablet interface allows full control from anywhere in the room.
Lung cancer remains Australia’s leading cause of cancer-related deaths, with 14,500 new cases annually. By improving nodule identification during procedures, LungVision aims to enhance early detection and increase survival rates.
In July 2024, the system secured an Innovative Technology Contract from Vizient, backed by recommendations from hospital experts.
12-03-2025